Reproductive Medicine Center
The Center for Reproductive Medicine of Jiangsu Province Hospital, founded in 1998, is one of the first approved centers for assisted reproductive technology by Chinese government. After decades of efforts under the leadership of Prof. Jiayin Liu, the center has earned a high reputation in the community of reproductive medicine. The center is recognized as one of the leading Centers in China.
The center has brought forth the first IVF, ICSI, IVM, PGD, and Oocyte freezing babies in Jiangsu Province since 1998. There are more than 7000 retrieval cycles of In Vitro Fertilization (IVF) in 2016, with excellent clinic outcomes and low complication profile. Therapeutic procedures such as mild or minimal stimulation approaches, cryopreservation and in vitro maturation of human oocytes, and pre-implantation genetic diagnosis, are being routinely performed.
The center currently employs 76 professionals, among whom 8 with Senior Professional titles, 14 with Associate Senior Professional titles, 2 as doctoral supervisors and 8 as master tutors.
The center invested tremendous efforts and fund in both clinical and basic research. As the Clinical Base of State Key Laboratory of Reproductive Medicine, it has hosted many national-level research projects and was rewarded numerous national and provincial prizes for its outstanding research and development achievements.
As the National Assisted Reproductive Technologies Training Base, the center has trained and certified more than 1000 doctors and embryologists from all over the country. Since 2005, the center developed the database for "Clinical Reproductive Medicine Management System", which has been used in various projects by more than 200 reproductive centers in China.
Dr. Jiayin Liu
Chief And Director
Senior Professor in Obstetrics And Gynecology
Vice-Director of State Key Laboratory of Reproductive Medicine
Professor Liu has been engaged in the clinic, scientific research, and teaching of Obstetrics and Gynecology for 35 years. Her research interests focus on gynecologic endocrinology and infertility for the past two decades. She is the founder of the center and continues to play a leadership role in the daily operation of the center.
Dr. Liu obtained her medical degree from Nanjing Medical University in 1982, and PhD in Genetics from Xiangya School of Medicine, Central South University in 2000, and further studied as a Senior Visiting Scholar in the Department of Obstetrics and Gynecology, Endocrinology, Cincinnati University, USA, from 1994 to 1996.
Dr. Liu is the board member and vice-director in professional societies of China, serving on the Reproductive Medical Professional Committee of Chinese Medical Association, Medical Genetics Committee of Chinese Medical Association, Division of Gynecological Endocrinology of Chinese Society of Obstetrics and Gynecology, Clinical Genetics committee of National Health and Family Planning Commission, and Human Assisted Reproductive Technology Committee of Maternal & Child Health Association.
Dr. Liu are the principal investigator of several major scientific research projects supported by Ministry of National Science and Technology in China, National Nature Science Foundations, and a number of national and provincial scientific research projects, published more than 200 peer-reviewed research articles in Chinese academic journals, and more than 80 publications in international academic journals.
Our center is one of the most comprehensive reproductive centers in China, offering infertility and assisted reproductive technology (ART) services in a highly skilled, well-organized manner, and an efficiently managed and patient-friendly environment. The experienced physicians integrate varieties of advanced medical and surgical approaches, and provide each patient individualized, high quality treatment. Physicians, embryologists, nurses and medical assistants cooperate closely to strive to achieve the highest and safest pregnancy and live birth rates for every couples. Patient care procedures are designed to deliver convenient, comfortable and yet low-cost service. Our slogan is “ Your Success Is Our Success”.
Our Center Offers Comprehensive Infertility Treatment Procedures. The Clinical Superiority Including:
1. Mild ovarian stimulation approach
Our center has conducted a series of mild ovarian stimulation protocols and embryo transfer strategy in assisted reproductive technologies. We strive to increase pregnancy and live birth rates, implantation rate has reached up to >45%, single embryo transfer rate has been to 71%, while reduce ovarian hyper-stimulation, multiple pregnancy, and perinatal complications. The twin pregnancy rate has been reduced to < 10%. Our aim is to provide a safe, efficient, affordable and comfortable "IVF" care.
2. Preimplantation Genetic Diagnosis/Screening (PGD / PGS)
The first chromosome translocation PGD baby was born in 2003, and first single gene defect PGD baby was born in 2013 in our center and Jiangsu Province. We were the first to apply array CGH and NGS technologies for routine clinical PGD/PGS, and genetic diagnosis in China. At present, more than 100 healthy PGD/PGS babies were born in our center.
3. Minimal ovarian stimulation and natural IVF cycle
Application of assisted reproductive technology for women with diminished ovarian reserve is a challenging task. A minimal and nature IVF program has been practiced for these patients for almost 10 years in our center, which has been successful in more than 8000 cycles and gotten comparable pregnancy rate of~30% per transfer. The accumulated experiences have been shared and recommended to many colleagues from the world.
4. Clinical pathway for screening etiology of infertility.
We established and promoted a clinical pathway of screening etiology for infertile couples. The clinical pathway has helped a large number of local doctors to treat infertile couples. The established procedure has recognized as an efficient and economical standard tool for primary diagnosis and treatment of infertility in China.
We Offer A Wide Range of Infertility Treatments, All Performed Under The Strictest Safety Standards, Including:
Intrauterine insemination (IUI)
In vitro fertilization (IVF)
Intracytoplasmic sperm injection (ICSI)
Preimplantation genetic diagnosis/screening (PGD/PGS)
Egg, sperm and embryo freezing, or cryopreservation
Assisted Hatching (AH)
In Vitro Maturation (IVM) of human oocyte
Egg donation, sperm donation
Minimal Invasive Surgery Center (laparoscopy and hysteroscopy)
Various male infertility treatments
Mild or minimal IVF approaches
Since 1998, our Department has begun to send excellent staff going abroad as visiting scholar to participate the training program and international conferences. Additionally, we received numerous of domestic and foreign colleagues for academic exchanges.